Covered recipient · General Payments record
JENNIFER L WARD
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,023.38
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $516.86 | 33 |
| Education | $108.44 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $288.74 | 20 |
| Janssen Biotech, Inc. | $238.45 | 10 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.76 | 1 |
| Almirall LLC | $20.40 | 1 |
| Regeneron Healthcare Solutions, Inc. | $18.39 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.90 | 1 |
| STRATA Skin Sciences, Inc. | $13.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378519 | CMS |
| ABBVIE INC. | $12.21 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378521 | CMS |
| ABBVIE INC. | $9.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378523 | CMS |
| ABBVIE INC. | $10.94 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378525 | CMS |
| ABBVIE INC. | $8.45 | 04/02/2024 | Education | Undisputed | 01/23/2026 | 1108378527 | CMS |
| ABBVIE INC. | $23.21 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378529 | CMS |
| ABBVIE INC. | $33.44 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378531 | CMS |
| ABBVIE INC. | $17.06 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378533 | CMS |
| ABBVIE INC. | $11.14 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378535 | CMS |
| ABBVIE INC. | $15.96 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378537 | CMS |
| ABBVIE INC. | $19.21 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378539 | CMS |
| ABBVIE INC. | $15.50 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378541 | CMS |
| ABBVIE INC. | $10.09 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378543 | CMS |
| ABBVIE INC. | $9.55 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378545 | CMS |
| ABBVIE INC. | $11.24 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378547 | CMS |
| ABBVIE INC. | $12.73 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378549 | CMS |
| ABBVIE INC. | $19.23 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378551 | CMS |
| ABBVIE INC. | $13.91 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378553 | CMS |
| ABBVIE INC. | $11.57 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378555 | CMS |
| ABBVIE INC. | $9.62 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108378557 | CMS |
| Almirall LLC | $20.40 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639900 | CMS |
| Janssen Biotech, Inc. | $22.12 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078350015 | CMS |
| Janssen Biotech, Inc. | $6.44 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078349991 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/15/2024 | Education | Undisputed | 01/23/2026 | 1078350019 | CMS |
| Janssen Biotech, Inc. | $6.10 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078350041 | CMS |
| Janssen Biotech, Inc. | $25.56 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078349982 | CMS |
| Janssen Biotech, Inc. | $6.86 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078349968 | CMS |
| Janssen Biotech, Inc. | $16.69 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078349961 | CMS |
| Janssen Biotech, Inc. | $29.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078350028 | CMS |
| Janssen Biotech, Inc. | $0.99 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078349985 | CMS |
| Janssen Biotech, Inc. | $24.20 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078350000 | CMS |
| Novartis Pharmaceuticals Corporation | $27.76 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087395122 | CMS |
| Regeneron Healthcare Solutions, Inc. | $18.39 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114387824 | CMS |
| STRATA Skin Sciences, Inc. | $13.66 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146583805 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.90 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152239692 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.